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Abstract
The goals of this paper are to bring awareness of the increasing diagnoses of diabetes in children, the resources
available to help educate the diabetic child and his/her family, the importance of early treatment, diet, and
compliance with treatment, and how the education readily available, treatment, and treatment goals differ
between European nations and the United States. Multiple topics will be discussed within this paper, the
pathophysiological differences between Type I Diabetes Mellitus (T1DM) and Type II Diabetes Mellitus
(T2DM), the differences in the treatment methods for each, nutritional needs, challenges throughout
childhood, and the differing outcomes for the two types of Diabetes. Also to be discussed are the differences
in how pediatric patients and their families are educated, and the educational tools that are used and readily
available in the United States vs. European Nations. Additionally, how the treatment plans and goals differ
between the United States and European Nations. Finally, hypothesizes will be drawn on the potential future
outcomes of the differing Diabetic treatments and educational methods that are practiced in the United States
and Europe.
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Introduction 
 
The goals of this paper are to bring awareness of the increasing diagnoses of diabetes in 
children, the resources available to help educate the diabetic child and his/her family, the 
importance of early treatment, diet, and compliance with treatment, and how the education 
readily available, treatment, and treatment goals differ between European nations and the United 
States.  Multiple topics will be discussed within this paper, the pathophysiological differences 
between Type I Diabetes Mellitus (T1DM) and Type II Diabetes Mellitus (T2DM), the 
differences in the treatment methods for each, nutritional needs, challenges throughout 
childhood, and the differing outcomes for the two types of Diabetes.  Also to be discussed are the 
differences in how pediatric patients and their families are educated, and the educational tools 
that are used and readily available in the United States vs. European Nations.  Additionally, how 
the treatment plans and goals differ between the United States and European Nations.  Finally, 
hypothesizes will be drawn on the potential future outcomes of the differing Diabetic treatments 
and educational methods that are practiced in the United States and Europe. 
Incident Rates of T1DM and T2DM in U.S. and European Children 
 
The prevalence of Diabetes in children living in the U.S. has been slowly and steadily 
increasing particularly in the last few decades.  The most current rates of Diabetes in children 
consist of more than 18,000 youth or approximately 78.3% of new cases per year are diagnosed 
with T1DM in 2008 and 2009 in the U.S. and more than 5,000 youth or 21% of the new cases 
each year (2008 and 2009) were diagnosed with T2DM (Centers for Disease Control and 
Prevention).  Using SEARCH for Diabetes Study, a six center observational study to determine 
population-based determination of physician-diagnosed diabetes in youth using four 
1
Kramer: Childhood Diabetes Type 1 and 2
Published by ScholarSpace @ JCCC, 2016
 
 
geographically based centers and two health plan-based centers in the U.S. to calculate the 
prevalence rates of diabetes in youth based on age, gender, ethnicity, and type; it was determined 
that in 2001 the approximate prevalence of T1DM in children of all ages and ethnicity was 
estimated at 1.54 per 1000 youth and approximate prevalence of T2DM in children in 2001 was 
estimated at 0.22 per 1000 youth, with T1DM accounting for approximately 80% of diabetic 
children and adolescents while T2DM is only approximately 20% of the remaining diabetes 
cases.  It is important to know that the incidence of T2DM varies greatly by ethnicity with Native 
Americans being effected at a rate of approximately 0.03 per 1000 youth in the 0-9 year age 
group and a staggering rate of 1.74 per 1000 youth in the 10-19 year age group, by contrast non-
Hispanic whites have an incidence rate of 0.0 per 1000 youth at 0-9 year age group and 0.19 per 
1000 youth in the 10-19 year age group, so a big variation of prevalence of T2DM depending on 
age and ethnicity is seen.  By comparison the estimated number of children with T1DM in the 
1970s ranged from 0.6 to 1.9 cases per 1000 youth including all youth under the age of 19, and 
those estimates were limited geographically and looked at data almost exclusively of non-
Hispanic white youth and these numbers did not count for T2DM as it was rarely if ever 
diagnosed in youth during this time, only recently being reported in clinical studies in the last 
few decades (American Academy of Pediatrics) (Kaufman).   
In Europe, the incidences of both T1DM and T2DM are increasing in significant 
numbers.  The current studies using data from EURODIAB, a European population based 
diabetes data base and registry that tracks all information regarding diabetes across 17 European 
nations, as well as DIAMOND, a diabetes database and registry that tracks T1DM worldwide, 
the study groups show an average of a 3.9% yearly increase in diagnosis of T1DM across 17 
European Nations when examining 15 years of records (1989-2003) and noting newly diagnosed 
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cases of T1DM in children under the age of 15 with the greatest percentage increase in diagnosed 
cases in those 5 years old or younger. The European study predicts that if the current trends of 
increase in new T1DM cases continues in addition to predicted population increases, then it is 
believed that the incidences in T1DM in the 5 and under age group will double sometime 
between 2005 and 2020.  In addition, the overall increase in T1DM in all children 15 years of 
age and under is predicted to increase by 70% (Patterson, Dahlquist and Gyürüs).  Europe, like 
the U.S., has also noted an increase in T2DM diagnoses in children the last few decades and has 
taken note of the rate of increase however, though Patterson, et. al. has made note of the increase 
of T2DM throughout European nations, he stresses that the increase in T2DM should not 
overshadow the rapid increase in T1DM diagnoses.  He does acknowledge that in a few 
European countries T2DM may be a predominant diabetes diagnosis in pediatric patients 
however, T1DM is and will probably continue to be the predominant type of diabetes throughout 
most European countries (Patterson, Dahlquist and Gyürüs).   
Etiology and Pathophysiology of Type 1 and Type 2 Diabetes in Children  
 
The pathophysiology of T1DM and T2DM differ in many ways, most notably which 
T1DM is considered by current research and studies to be an autoimmune disorder, while T2DM 
is basically thought of as an “acquired” metabolic disorder as a result of poor diet, obesity, lack 
of physical exercise and characterized by insulin resistance, insufficiency of the β cells in the 
pancreas, and an inability to properly metabolize glucose and lipids that can result in 
hyperglycemia. The most common type of diabetes found in children is T1DM.  In T1DM, 
current studies and research indicates that there is an autoimmune response that causes a T-Cell 
mediated attack on the β cells in the islet of the pancreas resulting in the destruction of the β cells 
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responsible for the production of insulin leading to either no insulin production from the 
pancreas or insufficient insulin production leaving the body unable to regulate blood sugar levels 
(BSL).  Most children who are diagnosed with T1DM have a prolonged asymptomatic period 
where no illness appears to be present until such a point where the β cell destruction has reached 
a point where the body can no longer regulate BSLs.  At this point the children with T1DM will 
present with polyuria (excessive urination), polyphagia (excessive hunger), and weight loss.  If 
the condition is not recognized early enough with the afore mentioned symptoms then 
ketoacidosis, defined as the presence of ketone bodies in the urine and/or blood as the result of 
the abnormal metabolism of fatty acids and denaturing of amino acids resulting in a dangerously 
low blood pH, can occur.  This is a true life or death emergent condition and if not treated 
promptly then death will soon follow.  Approximately 30% of children newly diagnosed with 
T1DM will present in Diabetic Ketoacidosis and require hospitalization to bring glucose levels 
under control the other 70% will not require hospitalization provided adequate outpatient 
facilities that are able to provide education and self-management care are accessible to the family 
(Janet Silverstein MD) (International Society for Pediatric and Adolecent Diabetes).   
Conformation of a T1DM diagnosis is the same as it is for T2DM, a fasting plasma 
glucose level of ≥126 ml/dL which should be confirmed by a repeat test showing similar results, 
a A1c ≥ 6.5% using a method certified by the National Glycohemoglobin Standardization 
Program and is standardized to the Diabetes Control and Complications assay, random plasma 
glucose of ≥ 200 ml/dL with symptoms of hyperglycemia, or plasma glucose level of ≥ 200 
ml/dL at 2hr on a Glucose Tolerance Test.  Additionally, an islet autoantibody test may be 
performed to detect autoantibodies in the plasma that may be responsible for the destruction of 
the β cells in the pancreas.  However, it must be noted that there are T1DM individuals who are 
4
JCCC Honors Journal, Vol. 7 [2016], Iss. 2, Art. 2
http://scholarspace.jccc.edu/honors_journal/vol7/iss2/2
 
 
negative for the islet autoantibodies, in which a plasma C-peptide test may provide some 
guidance in diagnosis although the interpretation of the test are controversial at this time 
(American Diabetes Association) (Porth) (Skies) (Janet Silverstein MD) (International Society 
for Pediatric and Adolecent Diabetes).   
In T2DM, which used to only be diagnosed in adults usually over the age of 40, the 
diagnoses in children, particularly adolescents are increasing rapidly over the last two decades 
(Giannini).   T2DM is typically considered to be an acquired disease or secondary disease caused 
by a metabolism disorder resulting from a poor diet that is high in carbohydrates and sugars, lack 
of adequate exercise, obesity, or in rare cases temporary T2DM may be brought on by 
pharmacological treatments for other disorders such as high doses or prolonged use of steroids 
for inflammatory or autoimmune conditions is one example, the symptomology and 
pathophysiological aspects of T2DM will clear up once the treatment is discontinued, or in the 
case of a syndrome or disorder causing the T2DM, the T2DM will clear up once the syndrome or 
disorder is properly treated or cured.  Of the above mentioned factors in developing T2DM, 
obesity poses the highest risk. However, new studies are showing that perhaps even more of a 
factor than obesity itself, is how the lipids are distributed through the body.  Those with higher 
levels of visceral fat and/or intramyocellular lipid content are at an even higher risk of T2DM 
than their peers with a similar BMI and lower levels of visceral fat and/or intramyocellular lipid 
content, as this group showed higher plasma glucose levels at 2 hr. on the Glucose test, and 
showed a higher insulin resistance (Giannini) (Constantino).  The diagnostic criteria for T2DM is 
the same as T1DM.  T2DM generally has a higher age at onset and the symptomology is similar 
to T1DM and includes polyuria, polydipsia (excessive thirst), weight loss, polyphagia, fatigue, 
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blurred vision, slow healing sores or frequent infections (International Society for Pediatric and 
Adolecent Diabetes). 
The pathophysiology of T2DM is complex, it basically involves first the individual 
becoming resistant to the insulin that is being produced by the β cells in the pancreas and/or β 
cell failure. The difference between insulin resistance and β cell failure is that with insulin 
resistance the cells throughout the body no longer respond appropriately to the normal hormonal 
action of insulin to pull glucose from the blood into the cells for utilization and storage whereas,  
β cell failure is due to the pancreatic β cells not producing adequate amounts of insulin to lower 
the BSL either due to exhaustion or cellular damage not due to autoimmune destruction.  The 
pancreatic islet β cells now work on producing even more insulin for the same levels of glucose 
present in the blood in effort to compensate for the resistance.  Eventually the pancreatic β cells 
are unable to compensate for the insulin resistance and hyperglycemia develops resulting in 
T2DM.  With obesity as well as more specifically increased levels of visceral fat and/or 
intramyocellular lipid levels, it is the increased adipose tissues and lipids that contributes to the 
insulin resistance although it is not for certain why or well understood.  It is to be noted that an 
increase of fat within the liver significantly increases the likelihood of developing T2DM, and as 
obesity rises among the youth this is becoming more and more of an issue that was typically 
reserved for adults.  The studies that have been done show that while obesity, genetics, physical 
activity, and diet all play a significant role in the development of T2DM, the highest incidences 
of the disorder is found in individuals whose body does not partition and store lipids in an ideal 
manner (Giannini).  It is important to note how vital it is to differentiate whether the child has 
T1DM or T2DM when diagnosing diabetes in any child, as the treatment, educational 
approaches, pathology, etiology, and outcomes will differ depending on the diagnosis.  As a 
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result, a child that is overweight and/or exhibits symptoms of both T1DM and T2DM it is 
thought that an islet autoantibody test would be useful in differentiating diagnosis of T1DM and 
T2DM.   A plasma C-peptide level may be indicated if the child has negative autoantibody levels 
however,  the readings of the measurements is a controversial issue in the medical community 
(Janet Silverstein MD) (International Society for Pediatric and Adolecent Diabetes) (Kaufman). 
Treatment for children with T1DM and T2DM 
 
 Treatment for both T1DM and T2DM is multifactorial but differ in some aspects, 
because of the differences in the pathophysiology and etiology of the two diseases, it is 
important to be able to differentiate between whether the child has T1DM or T2DM in order to 
achieve the best possible long-term outcomes in treatment, quality of life, and overall health.  It 
is important to note that when treating both T1DM and T2DM in children and adolescents it 
must be recognized that there will be additional psychological stresses on the diabetic child as 
well as the parents that are not seen with non-diabetic children.  These stresses revolve around 
fitting in with peers, frustration of not being able to eat whenever or whatever the child wants, 
fear of being excluded, and even the fear of hospitalizations.  The stresses that arise with 
parents involve getting the child to comply with treatment, the huge responsibility of managing 
diabetes, medications, diet, and multiple doctor appointments.  Additionally, the parents 
constantly live with the fear of their child having to be hospitalized, suffering organ or system 
damage due to diabetes, and even the fear of knowing their child may die prematurely due to 
complications of the disease. The stresses and psychological challenges facing children with 
diabetes often leads to increased rates of depression and conflicts with parents and if these 
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issues are not carefully addressed they can lead to lower treatment compliance which has its 
own set of short term and long term consequences (Naranjo) (Janet Silverstein MD).  
With T1DM the diagnosed child is dependent on insulin injections or pump for infusion 
of insulin to control BSL in the absence of adequate pancreatic β cells to produce the necessary 
insulin.  In addition, a diet that restricts refined carbohydrate intake and sugars is vital 
alongside a monitored but physically active lifestyle.  A healthy well rounded diet consisting of 
appropriate amounts of protein, adequate vegetables and fruits, and accurate counting of 
carbohydrates is necessary to keeping the BSL well controlled and need for frequent insulin 
adjustments to a minimum.  Working with a dietician who is experienced with diabetes and 
children as a member of the child’s Diabetes treatment team will help in managing the child’s 
BSLs through diet as much as possible, therefore helping to achieve the goal of optimal 
glycemic control as well as minimal insulin doses via Medical Nutrition Therapy.  In addition, 
this individual can provide support and ideas for the child’s parents as taste, preferences, and 
medical conditions change (Evert). The most concerning complication that can arise when 
treating T1DM in children is not only the ketoacidosis, but even just as concerning is 
hypoglycemic attacks which if they are left unchecked or are frequent, they can result in 
neuropsychological impairment and difficulty in learning with younger children whose brains 
are still developing rapidly (Janet Silverstein MD).   The current recommendation for BSL testing 
is at least four times a day and even more often for younger children as determined by the 
child’s physician, activity level, and dietary intake and is vital to maintaining good glycemic 
control (American Diabetes Association) (Janet Silverstein MD) (Skies).   
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Education for the family, parents, and the child is vitally important in managing T1DM 
and T2DM although the needed educational approaches differ depending on the type of 
diabetes.   An important part of the education process again is dietary needs, changes, and how 
to meet dietary needs of children without them feeling left out or different among their peers.  
It is recommended in treating both T1DM and T2DM that a registered dietitian with experience 
in working with children of all ages, as well as with diabetics be part of each child’s diabetic care 
team to educate and support both the parents and the children in finding a realistic dietary 
choices and solutions for the child and family as a whole (Evert) (Maffeis).  Besides educating 
the parents and family on diet, exercise, how to perform finger sticks to check BSL, 
administration of insulin as well as calculating doses, and what symptoms to look for regarding 
hypoglycemic episodes or uncontrolled hyperglycemia in T1DM, it is just as important to 
educate the child at his or her developmental level (Evert).   There are a variety of methods and 
educational goals for children of various developmental stages which will be discussed in a later 
section of this paper. 
With T2DM the treatment involves much the same as T1DM, diet, exercise and 
monitoring and control of BSL, as well as education (American Diabetes Association).  The 
control of BSLs in T2DM is mainly through diet, exercise, weight loss.  Since the pancreas is still 
producing adequate insulin levels in a Type II diabetic and the main issue is the body’s 
resistance to the insulin and β cell insufficiency, insulin therapy is not recommended except in 
severe cases of hyperglycemia and only as a temporary solution to reduction in BSL.  However, 
health practitioners are beginning to prescribe Metformin or other hypoglycemic 
pharmaceuticals to help reduce BSLs in children.  Metformin is the most common 
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pharmacological treatment of choice for T2DM that is normally prescribed for adults and only 
recently began clinical trials for pediatric and adolescent patients in 2014.  Physicians are 
beginning to prescribe Metformin to children and adolescents whose diabetes is poorly 
controlled using diet and exercise alone in hopes of gaining better glycemic control, as the 
Metformin can reduce A1c levels by an average of 1.5% and the Fasting Glucose Levels by an 
average of 25% (Diabetes Mall). The main goal in the treatment of T2DM is to treat the risk 
factors for the disease, namely obesity (Giannini) (American Diabetes Association).  In order to 
treat obesity diet must be managed carefully with not just a reduced caloric intake, but a 
change in the foods that are consumed.  The diet should become a lifestyle change and not just 
a diet and needs to include mostly fruits, vegetables, and small healthy proteins such as nuts, 
fish or lean meats while limiting carbohydrate intake and increasing fiber in the diet.  In 
addition, to help with the child’s compliance with the dietary changes the child should be 
involved in choosing and preparing the foods as appropriate for his/her age and development 
level (Evert) (Maffeis).   
Just as the diet is a very important component in addressing obesity and T2DM, exercise 
is also important in order to burn calories consumed, increase metabolism, and to improve 
uptake of glucose independent of insulin from the blood via the GLUT-4 transporters in the 
muscles, increases oxidative capacity, lipid oxidation and turnover, and improves glycogen 
synthesis which overall improves glucose metabolism.  Another important aspect of increased 
physical activity in the treatment of both obesity and T2DM is that the physical activity reduces 
insulin resistance over time (Giannini).  It is a reasonable goal to believe that T2DM if caught 
early, and well managed through weight loss, changed lifestyle including a healthy more natural 
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diet that limits carbohydrates and packed with fruits and vegetables, regular physical exercise, 
and limits other risk factors such as abnormal lipid levels and hypertension, that T2DM could 
actually go into remission or be cured. 
Comparison of Overall Long-Term Outcomes Between T1DM and T2DM Cohorts 
 
Recent studies on the long-term effects of T2DM in comparison to T1DM in children and 
adolescence, with the study focusing on mid to late adolescence, regarding future health and 
mortality impacts have shown that those with T2DM tend to have more health complications in 
the long term and a higher mortality rate.  It was found that those diagnosed with T2DM had 
significantly less favorable cardiac risk factors including lower HDL levels, higher serum 
triglyceride levels, higher BMI, and higher BP than their T1DM cohorts.  These cardiovascular 
risk factors for the T2DM group was found both early in the disease, within 2-5 years of 
diagnosis, as well as later on in the disease progression (Constantino).  Children and adolescence 
with T2DM tend to present with abnormal albuminuria, protein in the urine, their T1DM cohorts 
as well as macrovascular disease with a rate of 14.4 % for the T2DM compared to 5.7% for 
T1DM for the same cohort group.  An additional sobering find is a higher incidence of ischemic 
heart disease for T2DM children and adolescents at a 12.6% for T2DM children and adolescents 
compared to a 2.5% for matched cohorts with T1DM and duration of diabetes were similar.  
Studies have found that the fatality rate for those with early onset T2DM, defined as T2DM 
diagnosis in childhood or adolescence, was double compared to the fatality rate of those 
diagnosed with T1DM of similar age and duration of disease.  Most fatalities occurred in the 
prime of life and were a result of cardiovascular death. The results found in these studies give 
evidence to the significantly more aggressive nature of T2DM compared to T1DM 
(Constantino).  The studies that have been performed in comparing the long term effects of 
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T2DM in comparison to T1DM and the lifelong implications and outcomes expected are indeed 
truly sobering, showing a very real possibility of a much lower life expectancy for those 
diagnosed with T2DM and for the population as a whole as the rate of T2DM diagnosis 
continues to increase, unless some major changes are made in lifestyle and education beginning 
at a young age. 
 
Comparison of Treatment Goals and Patient Education for the U.S. and Europe 
 
Treatment goals and education of patients and their family members do differ between 
the U.S. and Europe.  In the U.S. the use of insulin is only advised for T1DM and not in T2DM 
unless reduction of BSL is or cannot be achieved with diet and exercise.   Europe does advocate 
the use of insulin regardless of which type of Diabetes is diagnosed in order to bring BSL within 
a tight optimal window and then manage the levels within that window using diet and exercise 
(International Society for Pediatric and Adolecent Diabetes). In addition, Metformin is 
increasingly prescribed in both countries to pediatric patients since 2000 and the rate of new 
Metformin prescriptions in children in general has tripled in the UK, with the highest increase of 
new prescriptions being to girls between the ages of 12-18.  This may be because besides 
Diabetes, Metformin is also being prescribed for Polycystic Ovarian Syndrome or PCOS as well 
as for diabetes and obesity treatment.  Metformin is still prescribed for younger children 
against manufacture’s recommendation for cases of uncontrolled diabetes though, the 
prescribing of Metformin in children younger than 11 has remained at a minimum showing only 
a handful of children in the UK being prescribed the drug (Hsia, Dawoud and Sutcliffe) 
(Metformin) (Diabetes Mall).  The US the incidence of Metformin prescriptions for pediatric 
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patients is not specifically recorded, it is estimated that approximately 70% of the children and 
adolescents with T2DM in the U.S. are on Metformin, a higher rate than the United Kingdom, 
and approximately 30% are taking more than one hypoglycemic pharmacological treatment 
(Kaufman). 
 European nations tend to stress diet, exercise, and education to help control diabetes 
and generally have a healthier diet and less sedentary lifestyle than their counterparts in the 
U.S., as demonstrated by many European nations rejecting many of the processed foods, food 
additives, and Genetically Modified Foods that are commonly consumed in the U.S. and their 
lifestyle that promotes daily physical activity.  Additionally, Europe has developed and 
implemented the SWEET project designed to improve and raise the standards of care for 
children and youth diagnosed with diabetes.  This program began by surveying families with 
children who have been diagnosed with diabetes as well as health care professionals treating 
pediatric diabetics regarding all aspects of care and treatment of the disease as well as 
compliance in treatment and education.  The SWEET project also created centers throughout 
Europe with the goal to house entire diabetic treatment teams consisting of pediatric 
endocrinologist, diabetic educators, diabetic specialty nurses, dieticians, and psychologist all 
experienced in pediatric diabetic care to help centralize access to the professionals needed to 
help manage the care and treatment of the diabetic child and provide age appropriate 
education and services for both the parents and the children.  While many centers were 
successful at being fully staffed with recommended professionals to treat the patients in the 
area, not all were adequately staffed with all of the needed professionals for example, many 
did not provide a psychologist on staff to help with the emotional needs of the diabetic child 
13
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and/or family members.  Besides being able to have all the needed health care professionals in 
one building to ease the treatment and care for the patient and family, just as importantly 
diabetic centers created by the SWEET project offered various educational methods and 
materials for all age groups and worked with the diabetic child in educating him or her based on 
their developmental level (Martin and Lange). 
Europe also employs a wide variety of creative educational methods to educate children 
about treatment, dietary choices, injections, and a wide variety of topics regarding managing 
diabetes, regardless of the type.  Various entrepreneurs, inventors, and companies within the 
European nations have come up with a variety of ways to help educate children in fun formats 
about diabetes, nutrition, and other health issues.  These methods which have been found 
through internet search include stuffed animals that can help not only comfort a young child 
but just as importantly show them in a child friendly way how to check BSLs and give insulin 
injections as well as how to distinguish the various injection sites and how to rotate testing and 
injection sites to prevent scar tissue buildup.  The stuffed animal also allows the child to 
practice and role play his or her treatment regimen to help gain mastery of his or her disease 
and needed treatment in a developmentally appropriate manner (Cramer).  Another European, 
German to be more specific, entrepreneur has developed a board game for children and 
adolescents with diabetes which is designed to teach children not just about the disease, but 
also about relationship between what they eat, medications, treatment and the disease in an 
entertaining format by initiating role play and a question and answer format (Hunsberger).  Yet 
another inventor in Germany has designed an electronic, multi-player game that can be 
programed to educate about various health issues as well as entertain the children playing.  The 
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idea behind this method of education is the fact that in the U.S. approximately 70% of homes 
with children have some type of electronic gaming system and the average child spends 
approximately one and a half hours a day playing on interactive electronic games.  Additionally, 
these games could be programed to be played on a computer or other network gamming 
system allowing for the child to play with other children, who may have the same condition, 
remotely and therefore providing an additional support network and friendships.  It has been 
demonstrated that diabetic children have a hard time discussing their disease with their peers 
but when a game related to diabetes was being played the child was able to better express and 
share his or her knowledge, thoughts and feelings regarding the disease and therefore helping 
to create social support via interplayer communication (Brown).  It is well known that the 
repetitiveness of game play among children is helpful in habit formation in young children and 
the process of playing games provides a fun method of education and interaction with peers 
and adults.  While these inventions were thought of and developed in European countries, it 
would not take much to market them globally, especially with the ease of international 
commerce in this day and age as well as the ease for many in the U.S., European nations, as 
well as other nations throughout the world where internet is not severely restricted, to order 
merchandise from websites and manufactures through the internet.   
Within the U.S., diabetes education overall seems a bit less creative than its European 
counterparts.  Upon a search on the internet, it was found that the majority of education 
materials for children was in the form of books, hundreds of different books about various 
topics regarding diabetes and written at a multitude of reading and comprehension levels (T-1 
Today Inc.).  While I am sure there are many of the same books and even different ones in 
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Europe, when searching online for “creative methods for educating children with diabetes in 
the U.S.,” the book list and the American Diabetes Association web page came up as the top 
methods in the U.S. for educating diabetic children.  The program set up by the American 
Diabetes Association to help educate children with T2DM is called STAR.  STAR stands for Stop, 
Think, Act, and Reflect.  The goal is for children with T2DM to: Stop before making a decision to 
evaluate it regarding its impact on their diabetes, for example should they watch TV or go for a 
walk, is the snack they are considering a good or OK option considering their current BSL; Think 
is to get the child to think about his or her options and choices before taking action and how 
each one effects their BSL and care plan; Act, act on the better choice for his or her health and 
BSL; Reflect, think about the progress made with each healthy choice and if a poor choice is 
made think about how to make a better one next time.  In addition to STAR the American 
Diabetes Association has a web page for teens which helps to answer questions regarding 
numerous teen topics such as alcohol use, sex, tobacco use, and other teen concerns such as 
dating (American Diabetes Association).  
Whether in the U.S. or Europe, it is very important to be able to educate children of all 
ages and their families regarding healthy lifestyle choices, and how to best care for their health 
as well as to be able to honestly and freely communicate with the health care providers.  This is 
so much more important when dealing with a chronic, lifelong health condition such as 
diabetes.  A study lead by Carol Raff, demonstrates how using interactive multimedia can help 
engage children of various ages but particularly elementary school age of 7-11 years of age, in 
their education about the health condition they have, participation in treatment, as well as 
improving communication between the child and the healthcare professional.  As a result, with 
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the use of multimedia to help engage the child and educate him or her, it is possible to have 
better health outcomes in the long run.  It is important that for the interactive multimedia to be 
effective in promoting better outcomes, communication with healthcare professionals, and 
participation in treatment that the interactive media be clinically relevant to the child’s health 
conditions in this instance it either deals with T1DM or T2DM depending on the diagnosis of the 
child (Raaff). 
    
Comparison of Hypothesized Long Term Outcomes for the U.S. and Europe 
 
  Overall outcomes for the U.S. regarding the long term outlook for today’s children who 
have T1DM and T2DM is poorer than that of European children.  This is more so when looking 
at outcomes for children with T2DM.  With the U.S. still having issues with access to health care 
for all individuals and insurance companies not paying for as many services while charging 
higher premiums, copays, and requiring families to meet higher deductibles, accessing the 
needed services for education, medication, and medical support to manage T1DM and T2DM 
among children will still pose an issue for children in the U.S. resulting in poorer outcomes for 
those who are unable to access the education and care needed.  This issue will primarily effect 
low to middle income families. In the European nations the access to health care is not 
dependent on the family’s income, and therefore everyone receives the same care regardless 
of their socioeconomic status especially in the care of children.  This discrepancy in the ability 
to access needed health care and health education in the way of dieticians and diabetic nurse 
educators as well as pediatric endocrinologist will create a difference in long term outcomes 
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with nations able to provide adequate care for majority regardless of income having a better 
long term outcome in the management and reduction of childhood diabetes. 
The U.S also has a poorer diet overall, with more processed foods available and it is 
often difficult to find foods that do not contain added sugars, food additives, and refined 
carbohydrates compared to European counterparts whose diet consist of more whole foods.  
The European Food Safety regulations severely limit the additives that are allowed in the foods 
processed and sold in European Union (United States Department of Agriculture).     The 
differences in diets between the U.S. and Europe will lead to significantly poorer outcomes for 
U.S. children diagnosed with T2DM especially however, it will also effect those with T1DM as 
well if the diet is not significantly changed over the course of the child’s lifetime and the typical 
processed foods and foods containing refined carbohydrates and added sugars are not sharply 
reduced or eliminated from the diet.  Additionally, with Europe’s better diet overall and 
restrictions on additives in food it would be easy to hypothesize that Europe will continue to 
have much lower rate of T2DM in children and adolescents than the U.S.   
As far as treatment models between the U.S. and Europe, the European nations have a 
much better model in place thanks to the SWEET project, better than anything the U.S. has in 
place.  This is demonstrated by diabetics in Europe having a “diabetic care team”  consisting of 
a group of professionals, at one of the numerous diabetic care centers through many parts of 
Europe where all needed medical professionals and care for the diabetic patient is in one 
building including but not limited to endocrinologist, dieticians, diabetic nurse educators, and 
some even have psychologist on staff as is recommended in order to address all aspects of 
diabetic care in one building (International Society for Pediatric and Adolecent Diabetes).  In the 
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U.S., most families have to schedule multiple appointments at sometimes multiple offices for 
complete diabetic treatment with multiple health professionals.  This also puts Europe ahead of 
the U.S. in being able to achieve better long term outcomes for children with both T1DM and 
T2DM.  The same could also be held true regarding education of both diabetic children and 
their parents with the creative educational tools, methods and emphasis within healthcare 
setting.  To be fair, it should be noted that the same educational methods and tools used and 
developed in Europe could also easily implemented and used in the U.S., therefore leveling the 
field so to speak in the area of education. 
Conclusions  
 
 Both T1DM and T2DM are complex metabolic diseases that have significant lifelong 
implications for children who are diagnosed with the conditions.  Treatment and education for 
each are similar, yet each has its unique specific treatment plans that needs to be created for 
each individual child through a multifocal approach of medicine, education, diet, and active 
lifestyle. 
The European nations look to be on the right track in spite of the increasing rates of 
T1DM and T2DM within their nations.  The rates of increase of T1DM and T2DM in the 
European nations is not as high as the U.S. overall though they are increasing significantly. 
Europe, with its universal healthcare system that spans more than 17 nations, has been able to 
track data easily and has taken the initiative to set up diabetic centers that can provide all 
treatment, monitoring, support, and education in one place.  This provides ease of obtaining 
needed treatment, support, and monitoring regardless of income and in addition the family 
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would not have to travel to multiple different offices to receive all the services needed.  
Additionally, it appears through internet searching that most of the creative methods for 
educating children and families dealing with diabetes come from European nations such as 
Germany.  The diet among Europeans generally has been more whole foods that are in season 
and fewer processed foods.  However, with the globalization of fast food and more American 
fast food restaurants being built abroad, maintaining the healthier eating habits and diet may 
prove to be a bit of a challenge. 
The U.S. has a huge challenge ahead to bring the prevalence of diabetes under control, 
especially T2DM.  With the U.S. having such a high incidence of childhood obesity compared to 
European nations, a more sedentary lifestyle, a diet which contains so many more processed 
foods and refined sugars and carbohydrates, and more issues with accessing health care, I 
believe it will take some big changes within the U.S. at the family level, in ability to access to 
needed healthcare and education regardless of family’s income, and better regulation of  
insurance policies regarding paying for needed services, and changes at the FDA level to bring 
about the needed changes in regards to additives allowed in our foods in order to lower the 
incidences of T1DM and  more specifically T2DM among children in the U.S.  At the family level 
parents must encourage and demonstrate healthy eating habits and diet as well as an active 
lifestyle for their children, as it is well known that children learn more form what they see than 
what they are told. Families in the U.S. need to be able to access education, healthy foods, and 
necessary health care regardless of the family income in order to have a healthier U.S., this is 
also true to have any hope in reducing the rates of T1DM and especially T2DM within the U.S. 
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and hopefully reverse the current course and prevent premature death due to T2DM, a largely 
preventable and treatable disease. 
  
21
Kramer: Childhood Diabetes Type 1 and 2
Published by ScholarSpace @ JCCC, 2016
 
 
References 
American Academy of Pediatrics. "The Burden of Diabetes Mellitus Amoung US Youth: Prevalence 
estimates from SEARCH for Diabetes in Youth Study." Pediatrics 118.4 (2006): 1500+. Web. May 
2016. 
<go.galegroup.com/ps/i.do?id=GALE%7CA153304529&v=2.1&u=jcl_jccc&it=r&p=EAIM&sw=w&
asid=f4f589ed3593de87099e4abea6848ce1>. 
American Diabetes Association. Being a Teen with Diabetes. June 2014. Web. Feburary 2016. 
<http://www.diabetes.org/living-with-diabetes/parents-and-kids/children-and-type-2/>. 
—. Children and Type 2 Diabetes. 1995-2016. Web. March 2016. <www.diabetes.org>. 
—. Type 1 Diabetes. 1995-2016. Web. Febuary 2016. <http://www.diabetes.org/diabetes-basics/type-
1/?loc=util-header_type1>. 
Brown, Stephen J. "Multi-player Interactive Electronic Game for Health Educaton." 1 July 1999. Google 
Patent. 22 Feburary 2016. 
<www.google.ch/patents/WO1999032201A1?cl=en&dq=using+play+to+teach+children+about+
diabetes&hl=de&sa=X&ved=0ahUKEwj8yNmW0lvLAhW>. 
Centers for Disease Control and Prevention. Diabetes Home: 2014 National Diabetes Statistic Report. 15 
May 2015. Web. June 2016. 
<http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html>. 
Constantino, Maria I., Lynda Molyneaux, Franziska Limacher-Gisler, Abdulghani Al-Saeed, Connie Luo 
and Ted Wu. "Long-term Complications and Mortaility in Young-onset Diabetes: Type 2 Diabetes 
is More Hazardous and Lethal than Type 1 Diabetes." Diabetes Care 36.12 (2013): 3863+. Web. 
May 2016. 
<www.go.galegroup.com/ps/i.do?id=GALE%7CA352752147&v=2.1&u=jcl_jccc&it=r&p=EAIM&s
w=w&asid=19913c9a03745bc37f0e91b1f7bb8e8b>. 
Cramer, Carol P. "Stuffed Toy and Method for Educating Children with Diabetes." 1 December 1998 . 
Google. Web. 22 Febuary 2016. <www.google.ch/patents/US5842870>. 
Diabetes Mall. "Metformin." 2014. DiabetesNet.com. Diabetes Mall. Web. March 2016. 
<https://www.diabetesnet.com/about-diabetes/diabetes-medications/metformin>. 
Evert, Alison B. RD, CDE. "Tools and Techniques for Working With Young People With Diabetes." 
Diabetes Spectrum 17.1 (2004): 8-13. Web. March 2016. 
<http://spectrum.diabetesjournals.org/content/17/1/8.full>. 
Giannini, Cosimo and Sonia Caprio. "Chapter 29: Type II Diabetes Metillus and Obesity in Youth." 
Radovick, Sally and Margaret H. MacGillivray. Pediatric Endocrinology A Practical Clinical Guide. 
Second. ExLibris Voyager, 2013. 523-535. E-Book. May 2016. 
<www.ezproxy.jccc.edu/login?url=http://dx.doi.org/10.1007/978-1-60761-395-4>. 
Hsia, Yingfen, et al. "Unlicenced use of Metformin in Children and Adolecence in the UK." British Journal 
of Clinical Pharmacology 73.1 (2011): 135-139. Web. May 2016. 
<http://www.ucl.ac.uk/promise/docs/metformin>. 
22
JCCC Honors Journal, Vol. 7 [2016], Iss. 2, Art. 2
http://scholarspace.jccc.edu/honors_journal/vol7/iss2/2
 
 
Hunsberger, Glenn E. "Diabetes Mellitus game US 6279908 B1." 28 August 2001. Google-Patents. Web. 
22 Feburaruy 2016. <www.google.ch/patents/US6279908>. 
International Society for Pediatric and Adolecent Diabetes. "Global IDF/ISPAD Guidline for Diabetes in 
Childhood and Adolecence PDF download." 2009. Inernational Diabetes Federation. Ed. Ragnar 
MD, PhD Hanas, et al. PDF. 23 March 2016. <http://www.idf.org/sites/default/files/Diabetes-in-
Childhood-and-Adolescence-Guidelines.pdf>. 
Janet Silverstein MD, Georgeanna Klingensmith MD, Kenneth Copeland MD, Leslie Plotnick MD, Francine 
Kaufman MD, Lori Laffel MD MPH, Larry Deeb MD, et al. "Care of Children and Adolescents With 
Type 1 Diabetes." Diabetes Care 28.1 (2005): 186-212. Online Document. April 2016. 
Kaufman, Francine Ratner MD. "Type 2 Diabetes in Children and Young Adults: A "New Epidemic"." 
Clinical Diabetes 20.4 (2002): 217-218. Web. May 2016. 
<http://clinical.diabetesjournals.org/content/20/4/217>. 
Maffeis, Claudio and Leonardo Pinelli. "Teaching Children with Diabetes About Adequate Dietary 
Choices." British Journal of Nutrition 99 (2008): S33-S39. Web. 22 Feburary 2016. 
<www.journals.cambridge.org/action/display/Abstract?fromPage=online&aid=1701556&fileld=
S0007114508892495>. 
Martin, Delphine and Karin, et. al Lange. "Recommendations for Age-Appropriate Education of Children 
and Adolecents with Diabetes and thier Parents in the European Union." Pediatric Diabetes 13. 
Suppl. 16 (2012): 20-28. Web. April 2016. 
<http://ub5he7kv4q.search.serialssolutions.com/?ctx_ver=Z39.88-
2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-
8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev
%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recommendations+for+age-app>. 
"Metformin." April 2016. Drugs.com. Inc. Cerner Multum. Web. May 2016. 
<https://www.drugs.com/metformin.html>. 
Naranjo, Diana and Hood, Korey. Psychological Challenges For Children Living With Diabetes. 21 August 
2013. Web. 22 Feburary 2016. <www.idf.org/psychological-challenges-children-living-diabetes>. 
Patterson, Christopher C, et al. "Incidence Trends for Childhood Type 1 Diabetes in Europe during 1989-
2003 and Predicted New Cases 2005-20: A Multicenter Prospective Registration Study." The 
Lancet 373.9680 (2009): 2027-2033. Web. May 2016. 
<http://search.proquest.com/docview/199023579?accountid=2200>. 
Porth, Carol Matttson. Essentials of Pathophysiology. 3rd. Philadelphia: Wolters Kluwer Health 
Limppincott Williams & Wilkins, 2011. Book. 
Raaff, Carol, Cris Glazebrook, and Heather Wharrad. "A Systematic Review of Interactive Multimedia 
Interventions to Promote Children's Communication with Health Professionals: Implications for 
Communicating with Overwieght Children." 2014. BMC Medical Informatics and Decision 
Making. Web. April 2016. <www.biomedcentral.com/1472-6947/14/8>. 
23
Kramer: Childhood Diabetes Type 1 and 2
Published by ScholarSpace @ JCCC, 2016
 
 
Skies, Kristin A. and William V. Tamborlane. "Chapter 28: Diabetes Mellitus in Children and Adolecence." 
Radovick, Sally and Margaret H. MacGillivray. Pediatric Endocrinology A Practical Clinical Guide. 
Second. ExLibris Voyager, 2013. 507-521. E-Book. May 2016. 
<www.ezproxy.jccc.edu/login?url=http://dx.doi.org/10.1007/978-1-60761-395-4>. 
T-1 Today Inc. Children with Diabetes-Books for Kids and Teens with Type 1. 20 August 2014. T-1 Today 
Inc. Web. 22 Feburary 2016. <www.childrenwithdiabetes.com/d_06_a00.htm>. 
United States Department of Agriculture. United States Mission to the European Union. 29 Janurary 
2016. Web. June 2016. <http://www.usda-eu.org/trade-with-the-eu/eu-import-rules/food-
additives/>. 
 
 
24
JCCC Honors Journal, Vol. 7 [2016], Iss. 2, Art. 2
http://scholarspace.jccc.edu/honors_journal/vol7/iss2/2
